These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10852535)

  • 1. The role of B cells and autoantibodies in multiple sclerosis.
    Archelos JJ; Storch MK; Hartung HP
    Ann Neurol; 2000 Jun; 47(6):694-706. PubMed ID: 10852535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of B cells in pathogenesis of multiple sclerosis.
    Nikbin B; Bonab MM; Khosravi F; Talebian F
    Int Rev Neurobiol; 2007; 79():13-42. PubMed ID: 17531836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells and antibodies in MS.
    Reindl M; Kuenz B; Berger T
    Results Probl Cell Differ; 2010; 51():99-113. PubMed ID: 19513636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.
    Hohlfeld R; Meinl E; Dornmair K
    J Neurol Sci; 2008 Nov; 274(1-2):5-8. PubMed ID: 18707694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of a B cell-dependent immunopathology in multiple sclerosis].
    Kuerten S; Pauly R; Blaschke S; Rottlaender A; Kaiser CC; Schroeter M; Fink GR; Addicks K
    Fortschr Neurol Psychiatr; 2011 Feb; 79(2):83-91. PubMed ID: 21253995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC; Harrer MD; Kuenzle S; Meier M; Goebels N
    Eur J Immunol; 2008 Jul; 38(7):2014-23. PubMed ID: 18521957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cells and multiple sclerosis.
    Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis.
    Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.
    Antel J; Bar-Or A
    J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-based vaccines: the future of multiple sclerosis therapy?
    Stüve O; Cravens PD; Eagar TN
    Expert Rev Neurother; 2008 Mar; 8(3):351-60. PubMed ID: 18345967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.
    Meinl E; Krumbholz M; Hohlfeld R
    Ann Neurol; 2006 Jun; 59(6):880-92. PubMed ID: 16718690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell differentiation in the CNS of patients with multiple sclerosis.
    Corcione A; Aloisi F; Serafini B; Capello E; Mancardi GL; Pistoia V; Uccelli A
    Autoimmun Rev; 2005 Nov; 4(8):549-54. PubMed ID: 16214094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 20. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.